PHILADELPHIA--(BUSINESS WIRE)--Hemispherx Biopharma, Inc. (AMEX: HEB) announced its financial results for the third quarter and nine months ended September 30, 2006, as well as a strategic update conference call and webcast scheduled for Wednesday, November 15, 2006 at 4:00pm EST on RNA therapeutics.
